Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Rebecca Cutler

Physician Assistant Charlotte, NC Physician Assistant

NPI 1982314977 CMS profile 11399484

11220 Elm Ln Ste 102, Charlotte, NC 28277

Open in the dashboard

General payments

$7,917

388 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rebecca Cutler of Charlotte, NC is reported in the CMS Open Payments database as having received $7,917 across 388 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,596 129
2024 General $3,282 152
2023 General $1,968 104
2022 General $70 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rebecca Cutler
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Rebecca Cutler were reported at $2,596. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Rebecca Cutler Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $70 $155 $48–$522 $149
2023 $1,968 $167 $52–$557 $160
2024 $3,282 $178 $55–$600 $164
2025 $2,596 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Novo Nordisk Inc $1,392 70 payments
  2. AstraZeneca Pharmaceuticals LP $999 34 payments
  3. AbbVie, Inc. $927 37 payments
  4. Lilly USA, LLC $662 39 payments
  5. Pfizer Inc. $420 26 payments
  6. Exact Sciences Corporation $376 19 payments
  7. Amneal Pharmaceuticals LLC $317 19 payments
  8. Amgen Inc. $269 20 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $258 11 payments
  10. Astellas Pharma US Inc $237 8 payments
  11. Other $2,060 105 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $7,823 387 payments
  2. Education $94 1 payment
Products named General payments · program years 2022–2025
  1. RYBELSUS $619 40 payments
  2. Ozempic $596 39 payments
  3. FARXIGA $530 18 payments
  4. Wegovy $508 21 payments
  5. VRAYLAR $415 13 payments
  6. AIRSUPRA $394 10 payments
  7. MOUNJARO $376 19 payments
  8. Cologuard Collection Kit $376 19 payments
  9. UNITHROID $317 19 payments
  10. UBRELVY $303 17 payments
  11. Other $5,671 313 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

388 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record